Cyted Health

Redefining digestive health by pioneering non-endoscopic diagnostics, enabling early detection of diseases and access to care for everyone, everywhere.

[Cyted Health @CytedHealth]

Our EndoSign® cell collection device has received 510(k) clearance from the FDA, enabling earlier and more efficient detection of esophageal pre-cancer and other conditions.

#DetectToProtect #FDA

[Cyted Health @CytedHealth]

Consultant Upper GI Surgeon Craig Vickery shared how @WestSuffolkNHS integrated EndoSign® into its #reflux pathway, reducing wait times for an appointment.

Read more: https://t.co/nj4Yy1oBHz

#EndoSign

[Cyted Health @CytedHealth]

EndoSign® is not designed to replace endoscopy.

It's designed to help identify which patients are most likely to benefit from it, supporting more targeted referrals and helping protect endoscopy capacity.
https://t.co/iNy4K0SbK5

#Endoscopy #EndoSign

[Cyted Health @CytedHealth]

Persistent #reflux shouldn't be ignored.

@HeartburnCancer UK's blog highlights Jess’s Rule, encouraging GPs to review patients presenting three times with the same symptoms. Earlier investigation can make a difference:

Discover EndoSign® for #heartburn: https://t.co/vEEKglcwNx

[Healio Gastroenterology @HealioGastro]

💣 Big data drop at #ACG2026! @CytedHealth’s #BarrettsEsophagus test delivers 90% sensitivity and 86% specificity 💥

🗨️ Hope on the horizon for 9️⃣0️⃣% of undiagnosed BE patients in the U.S., says Dr. Marcel Gehrung https://t.co/1FxU2NsdxN

[Business-News-Today.com @BNTBriefing]

@CytedHealth’s EndoSign detects Barrett’s esophagus with 90% sensitivity in US study https://t.co/hzCzSEwMV4 EndoSign achieved 90% sensitivity and 86% specificity for Barrett's esophagus in a prospective 324-participant US study, with successful cell collection in 95% of patients. Cyted Health also reported 100% sensitivity for dysplasia and esophageal cancer, but positive results still require endoscopy and the molecular test itself is not FDA-cleared. #CytedHealth #EndoSign #DETECTME #BarrettsEsophagus #EsophagealCancer #MolecularDiagnostics #EarlyDetection #MedicalDevices #Gastroenterology #ACG2026

[Cyted Health @CytedHealth]

Changes to #FIT criteria are expected to increase NHS #endoscopy activity by 35 %. With services already under pressure, effective triage is more important than ever.

Read how EndoSign® can help protect capacity: https://t.co/xC7ibB5B99

[Cyted Health @CytedHealth]

We’re pleased to welcome Thomas A. West as Board Chair and Epstein, Robert as Non-Executive Director at Cyted.

Their combined expertise will be invaluable as we continue to bring earlier, more accurate detection of esophageal disease to more patients.

https://t.co/3fts51jVn3

[Cyted Health @CytedHealth]

What support is available to help teams deliver EndoSign® in the NHS?

We provide training and ongoing support, with a cascade training model to help build sustainable local expertise.

Learn more: https://t.co/rfPcTigMNk

#EndoSign #Gastroenterology #NHS

[Cyted Health @CytedHealth]

20 % of the UK population experiences GORD, yet serious pathology is rare.

How can services identify high-risk patients without overwhelming endoscopy pathways?

Read our article that explores risk stratification with EndoSign®: https://t.co/79kI2ex3j4

#GORD #EndoSign

[Cyted Health @CytedHealth]

Many #NHS services are moving beyond endoscopy-first approaches with risk stratification, nurse-led assessment and less invasive investigations with EndoSign®.

How has your pathway evolved? https://t.co/iNy4K0SbK5

[Cyted Health @CytedHealth]

How do patients respond to EndoSign?

A study with EndoSign® reported a 95.3 % swallow success rate and no adverse complications.

Read the study from @gastroendonews : https://t.co/OQIFRetBMU

[Cyted Health @CytedHealth]

Eddie lived with heartburn for 40+ years, unaware it could lead to cancer.

One capsule sponge test detected early cell changes, leading to treatment before the disease could progress.

Read his story: https://t.co/qlxucbfIq0

#Reflux #EndoSign #OesophagealCancer

[Cyted Health @CytedHealth]

Not every Barrett's oesophagus patient carries the same cancer risk. So, should everyone follow the same surveillance pathway?

Read our article in @thenhenews that discusses how biomarker-based risk stratification can support more targeted care: https://t.co/n069GYc7Ff

[Cyted Health @CytedHealth]

A UK study found sponge-based surveillance detected more high-grade dysplasia or adenocarcinoma than endoscopy.

A second study with EndoSign® reported a 95.3 % swallow success rate and no adverse complications.

Read more in @gastroendonews:
https://t.co/OQIFRet3Xm

[Cyted Health @CytedHealth]

Clinicians are being urged to reduce low yield endoscopies, and earlier risk stratification could be key to this.

EndoSign® capsule sponge testing offers minimally invasive triage to support targeted referral.

Learn more: https://t.co/Kn5wUCn5S3

#Endoscopy #BarrettsOesophagus

[Cyted Health @CytedHealth]

What is the difference between capsule endoscopy and capsule sponge technology?

Explore more of our frequently asked questions:

#UpperGI #Diagnostics #OesophagealCancer #Reflux #Endoscopy

[Cyted Health @CytedHealth]

31-MarYou may know EndoSign® as the ‘pill on a string’ – but what is it?

A minimally invasive triage tool that collects oesophageal cells to assess #reflux and Barrett’s risk.

Learn more: https://t.co/Kn5wUCn5S3

#OesophagealCancer #Reflux

[Cyted Health @CytedHealth]

Oesophageal cancer is often diagnosed late, impacting outcomes. 5 year survival can be ~95 % when detected early, but reduces to 5-40 % at advanced stages.

EndoSign® enables minimally invasive risk stratification for targeted referrals.

Learn more: https://t.co/Kn5wUCmy2v

[Cyted Health @CytedHealth]

Up to 75 % of UK #gastroscopies may be performed in patients with <1 % cancer risk.

Earlier risk stratification could reduce low yield procedures. EndoSign® supports minimally invasive assessment to better target #endoscopy.

Learn more: https://t.co/Kn5wUCn5S3

[Cyted Health @CytedHealth]

What do patients think of EndoSign® capsule sponge test?

Read more about the patient experience here:

#HeartburnHealthCheck #OesophagealCancer #EarlyDiagnosis #NHSInnovation